Medilines Distributors Inc. yesterday said it sees steady growth as it seeks to participate in government-led health projects.
This after the company reported it closed 2022 with a profit of P191.97 million, up 13.16 percent from PP169.63 million the prior year.
Sales reached P1.96 billion, up 24 percent from P1.58 billion in 2021, of which more than half was for cancer therapy equipment worth P1.1 billion, the company said.
“ We remain bullish with the industry for this year, and we believe that we are in the right position to take on more opportunities as we sustain our leadership in the medical equipment and consumables distribution market,” said Patricia Yambing, Medilines president.
“Our focus remains on business strategies that will deliver profitable and sustainable growth over time. We are looking at a steady growth in 2023, as the government implements its Philippine Health Facility Development Plan (PHFDP),” Yambing added.
PHFDP aims to create regional specialty centers across the country.
The government is also looking to expand its dialysis wards in state-owned hospitals to support the widening coverage of the Philippine Health Insurance Corp.’s (PhilHealth) dialysis treatments.
The company’s dialysis segment showed notable increase in its distribution of the consumables product line, reflecting an astounding growth of 76 percent year-on-year.
Medilines said the expansion of its dialysis consumables line of products is one of the pillars of its growth strategy. – Ruelle Castro
